LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 223

Search options

  1. Book: Kronstadts medizinisch-pharmazeutische Bibliographie der Jahre 1530 - 1930

    Huttmann, Arnold

    (Veröffentlichungen des Südostdeutschen Kulturwerks : Reihe B, Wissenschaftliche Arbeiten ; 77)

    2000  

    Author's details Arnold Huttmann
    Series title Veröffentlichungen des Südostdeutschen Kulturwerks : Reihe B, Wissenschaftliche Arbeiten ; 77
    Veröffentlichungen des Südostdeutschen Kulturwerks
    Veröffentlichungen des Südostdeutschen Kulturwerks ; Reihe B, Wissenschaftliche Arbeiten
    Collection Veröffentlichungen des Südostdeutschen Kulturwerks
    Veröffentlichungen des Südostdeutschen Kulturwerks ; Reihe B, Wissenschaftliche Arbeiten
    Keywords Braşov ; Medizin ; Tiermedizin ; Pharmazie
    Subject Tierheilkunde ; Veterinärmedizin ; Humanmedizin ; Heilkunst ; Medicine ; Arzneikunde ; Arzneimittelkunde
    Language German
    Size 159 S. : Ill.
    Publisher Verl. Südostdt. Kulturwerk
    Publishing place München
    Publishing country Germany
    Document type Book
    HBZ-ID HT012765844
    ISBN 3-88356-150-9 ; 978-3-88356-150-9
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Article ; Online: Neutropenia-related aspergillosis in non-transplant haematological patients hospitalised under ambient air versus purified air conditions.

    Friese, Christina / Breuckmann, Katharina / Hüttmann, Andreas / Eisele, Lewin / Dührsen, Ulrich

    Mycoses

    2023  Volume 66, Issue 6, Page(s) 505–514

    Abstract: Background: To reduce the risk of invasive aspergillosis (IA), air purification by high-efficiency particulate air filtration and laminar air flow (HEPA/LAF) is standard of care in allogeneic blood stem cell transplantation. Its use in non-transplant ... ...

    Abstract Background: To reduce the risk of invasive aspergillosis (IA), air purification by high-efficiency particulate air filtration and laminar air flow (HEPA/LAF) is standard of care in allogeneic blood stem cell transplantation. Its use in non-transplant haematological patients is inconsistent.
    Objectives: We sought to assess the incidence and outcome of pulmonary IA in non-transplant patients with life-threatening neutropenia by comparing an ambient air hospitalisation period (2008-2011) with a subsequent HEPA/LAF hospitalisation period (2012-2014).
    Patients and methods: We compared 204 consecutive patients with acute myeloid leukaemia, acute lymphoblastic leukaemia or aplastic anaemia completing 534 neutropenia-related hospitalisations under ambient air conditions with 126 such patients completing 437 neutropenia-related hospitalisations under HEPA/LAF conditions. IA was defined using the 2008 EORTC/MSG criteria.
    Results: Within a 7-year study period, we observed one 'proven', three 'probable' and 73 'possible' IAs, most often during acute leukaemia remission induction. Their frequency rose with increasing duration of life-threatening neutropenia (1-10 days, 1.8%; >40 days, 35.2%) and concomitant severe anaemia (0 days, 3.2%; >20 days, 31.0%). Multiple logistic regression revealed a strong correlation between IA incidence and hospitalisation under HEPA/LAF conditions (odds ratio [OR], 0.368 [95% confidence interval, 0.207-0.654]; p < .001) and duration of neutropenia (OR, 1.043 [1.023-1.062] per day; p < .001) and anaemia (OR, 1.044 [1.008-1.081] per day; p = .016). IA-associated fatal outcomes were non-significantly reduced under HEPA/LAF (OR, 0.077 [0.005-1.151]; p = .063). The protective effect of HEPA/LAF was not seen under posaconazole prophylaxis (OR, 0.856 [0.376-1.950]; p = .711).
    Conclusions: Implementation of HEPA/LAF was associated with a significant reduction in neutropenia-related IA in non-transplant haematological patients.
    MeSH term(s) Humans ; Aspergillosis/drug therapy ; Hematology ; Neutropenia/complications ; Invasive Pulmonary Aspergillosis/etiology ; Invasive Pulmonary Aspergillosis/complications ; Leukemia, Myeloid, Acute/complications
    Language English
    Publishing date 2023-02-23
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 392487-7
    ISSN 1439-0507 ; 0933-7407
    ISSN (online) 1439-0507
    ISSN 0933-7407
    DOI 10.1111/myc.13576
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book ; Thesis: Untersuchungen zur Pharmakokinetik und Pharmakodynamik des Podophyllotoxinderivates NK 611

    Hüttmann, Andreas

    Resultate der Phase-I-Studie

    1995  

    Author's details vorgelegt von Andreas Hüttmann
    Language German
    Size 99 Bl. : graph. Darst.
    Edition [Mikrofiche-Ausg.]
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Hamburg, Univ., Diss., 1995
    Note Mikrofiche-Ausg.: 1 Mikrofiche : 24x
    HBZ-ID HT007461184
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  4. Article: Report on important cardiovascular work from Romanian literature.

    HUTTMANN, A

    Zeitschrift fur Kreislaufforschung

    2007  Volume 37, Issue 15-16, Page(s) 461–467

    Title translation Bericht über wichtige Herz- und Kreislaufarbeiten aus der rumänischen Literatur.
    MeSH term(s) Blood Circulation ; Cardiology ; Ethnic Groups ; Humans ; Romania
    Language German
    Publishing date 2007-12-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 124482-6
    ISSN 0044-295X
    ISSN 0044-295X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book ; Online: Erfolgreich studieren mit Soft Skills

    Hüttmann, Andrea

    Die eigene Persönlichkeit wirkungsvoll stärken

    2016  

    Abstract: Wie kann ich mein Studium erfolgreich meistern? Studiere ich überhaupt das Richtige? Wie funktioniert effektives Lernen? Sind Praktika wirklich so wichtig? - Es gibt viele Fragen, die Studierende hierzulande umtreiben. Nur ein Teil von ihnen scheint ... ...

    Author's details von Andrea Hüttmann
    Abstract Wie kann ich mein Studium erfolgreich meistern? Studiere ich überhaupt das Richtige? Wie funktioniert effektives Lernen? Sind Praktika wirklich so wichtig? - Es gibt viele Fragen, die Studierende hierzulande umtreiben. Nur ein Teil von ihnen scheint befriedigende Antworten zu finden, denn immerhin bricht in Deutschland jeder dritte Hochschul- und jeder vierte Fachhochschulstudent sein Studium ab. Andrea Hüttmann ist eine - gerade im Coaching von Studenten - erfahrene Expertin. Sie räumt mit diversen Mythen rund um das Studieren auf und zeigt Ihnen, wie Sie mit der richtigen Anwendung von Soft Skills erfolgreich und mit Freude studieren. Sie lernen Ihr Selbstbild zu überprüfen, Ihre Persönlichkeit zu festigen, für sich selbst Verantwortung zu übernehmen und erfolgreich mit anderen zu kommunizieren und zu kooperieren. Viele Beispiele und konkrete Verhaltenstipps erleichtern Ihnen die Umsetzung in die Praxis. Der Inhalt  • Die Kunst sich selbst zu führen  • Die Kunst zu kooperieren  • Studentische Kompetenzen  • Die wichtigsten Lebensprinzipien Die Autorin Andrea Hüttmann ist Professorin an der accadis Hochschule Bad Homburg sowie Leiterin des Fachbereichs „Communication Skills“ und der Internen Hochschulkommunikation. Sie ist Expertin f ür Soft Skills, Persönlichkeitsentwicklung sowie Human- und Unternehmenskommunikation. Als Coach berät und begleitet sie Studierende, Privatpersonen und Unternehmen bei Veränderungsvorhaben, Entwicklungswünschen und in Fragen der Kommunikation.
    Keywords Business ; Careers ; Success in business
    Language German
    Size Online-Ressource (XX, 232 S. 32 Abb), online resource
    Edition 1. Aufl. 2016
    Publisher Springer Fachmedien Wiesbaden
    Publishing place Wiesbaden ;s.l
    Document type Book ; Online
    ISBN 9783658099695 ; 9783658099701 ; 3658099690 ; 3658099704
    DOI 10.1007/978-3-658-09970-1
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  6. Article: Rituximab bei der CD20-positiven akuten lymphatischen Leukämie. Stellenwert des gegen CD20 gerichteten Antikörpers Rituximab

    Hüttmann, Andreas

    Wtz-Journal

    2016  Volume -, Issue 1, Page(s) 10

    Language German
    Document type Article
    ZDB-ID 2530214-0
    ISSN 1869-5892
    Database Current Contents Medicine

    More links

    Kategorien

  7. Book: Medizin im alten Siebenbürgen

    Huttmann, Arnold / Huttmann, Georg-Valentin / Offner, Robert

    Beiträge zur Geschichte der Medizin in Siebenbürgen

    2000  

    Author's details Arnold Huttmann. Hrsg. von Robert Offner
    Keywords Siebenbürgen ; Medizin ; Geschichte ; Gesundheitswesen ; Huttmann, Arnold
    Subject Gesundheitsdienst ; Gesundheitssystem ; Gesundheitswirtschaft ; Medizinalwesen ; Medizinalsystem ; Humanmedizin ; Heilkunst ; Medicine
    Language German
    Size 574 S., Ill., 24 cm
    Publisher Ed. hora
    Publishing place Hermannstadt/Sibiu
    Publishing country Romania
    Document type Book
    Note Literaturangaben. - Bibliogr. A. Huttmann S. 473 - 523
    HBZ-ID HT012898265
    ISBN 973-99187-7-8 ; 978-973-99187-7-0
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  8. Article ; Online: Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation.

    Koch, Karoline / Richter, Julia / Hanel, Christoph / Huttmann, Andreas / Duhrsen, Ulrich / Klapper, Wolfram

    Haematologica

    2022  Volume 107, Issue 9, Page(s) 2144–2153

    Abstract: The sole distinguishing feature of follicular lymphoma grade 3B and diffuse large B-cell lymphoma is the growth pattern assessed by histopathology. Diffuse growth defines diffuse large B-cell lymphoma but the clinical relevance of this finding when ... ...

    Abstract The sole distinguishing feature of follicular lymphoma grade 3B and diffuse large B-cell lymphoma is the growth pattern assessed by histopathology. Diffuse growth defines diffuse large B-cell lymphoma but the clinical relevance of this finding when occurring in follicular lymphoma grade 3B is uncertain. To address this issue, individual and coexisting follicular lymphoma grade 3B and diffuse large B-cell lymphoma were separated and analyzed for immunophenotype and molecular genetic features by fluorescence in situ hybridization, targeted sequencing and gene expression profiling. Clinical features of follicular lymphoma grade 3B with and without coexisting diffuse large B-cell lymphoma were studied in homogeneously treated patients from a prospective randomized trial. Follicular lymphoma grade 3B and diffuse large B-cell lymphoma frequently show an intermediate growth pattern and/or occur simultaneously in the same tissue at the time of initial diagnosis. When occurring simultaneously follicular lymphoma grade 3B and diffuse large B-cell lymphoma do not differ significantly for genetic aberrations or phenotype but have distinct gene expression features reflecting a divergent microenvironment. Follicular lymphoma grade 3B with and without coexisting diffuse large B-cell lymphoma do not differ for major clinical parameters such as International Prognostic Index, response to immuno-chemotherapy, progression or overall survival. Follicular lymphoma grade 3B and simultaneous diffuse large B-cell lymphoma are molecularly homogenous. Histological detection of diffuse large B-cell lymphoma is not associated with features of a more aggressive disease and does not reflect transformation or progression of follicular lymphoma grade 3B.
    MeSH term(s) Humans ; Immunophenotyping ; In Situ Hybridization, Fluorescence ; Lymphoma, Follicular/diagnosis ; Lymphoma, Follicular/genetics ; Lymphoma, Large B-Cell, Diffuse/diagnosis ; Lymphoma, Large B-Cell, Diffuse/genetics ; Lymphoma, Large B-Cell, Diffuse/pathology ; Prospective Studies ; Tumor Microenvironment/genetics
    Language English
    Publishing date 2022-09-01
    Publishing country Italy
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2333-4
    ISSN 1592-8721 ; 0017-6567 ; 0390-6078
    ISSN (online) 1592-8721
    ISSN 0017-6567 ; 0390-6078
    DOI 10.3324/haematol.2021.279351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas.

    Demirdas, Sedat / Hense, Jörg / Dührsen, Ulrich / Hüttmann, Andreas

    Oncology research and treatment

    2019  Volume 42, Issue 11, Page(s) 580–588

    Abstract: Background: Histologic transformation (HT) of indolent B-cell lymphomas into an aggressive form can occur simultaneously (primary HT, pHT) or sequentially after a preceding diagnosis of indolent lymphoma (secondary HT, sHT). The clinical course after ... ...

    Abstract Background: Histologic transformation (HT) of indolent B-cell lymphomas into an aggressive form can occur simultaneously (primary HT, pHT) or sequentially after a preceding diagnosis of indolent lymphoma (secondary HT, sHT). The clinical course after diagnosis of HT is variable.
    Objectives: To describe the outcome of treatment in pHT and sHT patients.
    Methods: We retrospectively analyzed HT cases with an underlying follicular lymphoma, nodal marginal zone lymphoma, extranodal marginal zone lymphoma, lymphoplasmacytic lymphoma, or small lymphocytic lymphoma at our institution. Kaplan-Meier estimates were used to calculate progression-free survival (PFS) and overall survival (OS).
    Results: Ninety-two HT patients were identified, 38 with pHT and 54 with sHT. In sHT, time-to-transformation was not influenced by the preceding treatment strategy of the indolent lymphoma component. In pHT, median PFS was 61 months (95% CI 27-61), and OS was not reached. In sHT, median PFS and OS was 14 months (95% CI 9-32) and 42 months (95% CI 16-90), respectively. Significant differences between pHT and sHT in PFS (p = 0.002; Hazard ratio [HR] 2.30, 95% CI 1.36-3.91) and OS (p = 0.0001; HR 3.30, 95% CI 1.81-6.03) were observed. Response to treatment for transformation was highly prognostic of PFS and OS (p < 0.0001).
    Conclusions: The outcome in pHT cases is favorable and signifi-cantly better than in sHT cases. Failure to achieve a remission after treatment for transformation confers a dismal pro-gnosis.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Female ; Humans ; Lymphoma, B-Cell, Marginal Zone/diagnosis ; Lymphoma, B-Cell, Marginal Zone/mortality ; Lymphoma, B-Cell, Marginal Zone/therapy ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Tomography, X-Ray Computed ; Treatment Outcome
    Language English
    Publishing date 2019-09-19
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2760274-6
    ISSN 2296-5262 ; 2296-5270
    ISSN (online) 2296-5262
    ISSN 2296-5270
    DOI 10.1159/000502754
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.

    Sakarou, Maria / Eisele, Lewin / Dührsen, Ulrich / Hüttmann, Andreas

    European journal of haematology

    2019  Volume 102, Issue 3, Page(s) 241–250

    Abstract: Objectives: The GMALL-B-ALL/NHL2002 protocol is effective in Burkitt lymphoma/leukemia (BL). Its role in other aggressive lymphomas and in patients with simultaneous central nervous system (CNS) and peripheral involvement is unclear.: Methods: This ... ...

    Abstract Objectives: The GMALL-B-ALL/NHL2002 protocol is effective in Burkitt lymphoma/leukemia (BL). Its role in other aggressive lymphomas and in patients with simultaneous central nervous system (CNS) and peripheral involvement is unclear.
    Methods: This is a retrospective outcome analysis in 76 patients with BL (n = 26), B-lymphoblastic lymphoma (B-LBL; n = 3), diffuse large B-cell lymphoma (DLBCL; n = 31), mantle cell lymphoma (MCL; n = 6), transformed B-cell non-Hodgkin lymphomas (tB-NHL; n = 7), and T-cell NHL (T-NHL; n = 3) treated with the GMALL-B-ALL/NHL2002 protocol.
    Results: 73.1% of scheduled chemotherapy cycles were administered. Treatment was discontinued in 38 patients (50.0%) due to progression (n = 14), toxicities (n = 11), scheduled treatment change (n = 6), and unknown reasons (n = 7). All BL/B-LBL patients were treated first-line, and at a median follow-up of 124.7 months, median progression-free survival was not reached. In DLBCL, median PFS was 68.4 months in first-line treated patients and 3.7 months in relapsed/refractory patients. CNS involvement was present in 10 non-BL/B-LBL cases and did not have a negative impact on survival in first-line treated patients but was fatal in all relapsed/refractory patients.
    Conclusion: This study confirmed the activity of the GMALL-B-ALL/NHL2002 protocol in BL/B-LBL. It was also effective in first-line treated non-BL/B-LBL lymphomas with and without simultaneous CNS-/peripheral involvement, but ineffective in relapsed/refractory disease.
    MeSH term(s) Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Burkitt Lymphoma/drug therapy ; Burkitt Lymphoma/mortality ; Burkitt Lymphoma/pathology ; Central Nervous System Neoplasms/drug therapy ; Central Nervous System Neoplasms/secondary ; Drug Resistance, Neoplasm ; Female ; Humans ; Lymphoma, Non-Hodgkin/drug therapy ; Lymphoma, Non-Hodgkin/mortality ; Lymphoma, Non-Hodgkin/pathology ; Male ; Medication Adherence ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Recurrence ; Survival Analysis ; Treatment Outcome ; Young Adult
    Language English
    Publishing date 2019-01-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 392482-8
    ISSN 1600-0609 ; 0902-4441
    ISSN (online) 1600-0609
    ISSN 0902-4441
    DOI 10.1111/ejh.13199
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top